148 related articles for article (PubMed ID: 21327537)
21. Selectivity Improvement for Spectrofluorimetric Determination of Oseltamivir Phosphate in Human Plasma and in the Presence of Its Degradation Product.
Omar MA; Derayea SM; Mostafa IM
J Fluoresc; 2017 Jul; 27(4):1323-1330. PubMed ID: 28293815
[TBL] [Abstract][Full Text] [Related]
22. Development and validation of stability indicating method for determination of sertraline following ICH guidlines and its determination in pharmaceuticals and biological fluids.
Walash MI; Belal FF; El-Enany NM; Elmansi H
Chem Cent J; 2011 Oct; 5(1):61. PubMed ID: 21996025
[TBL] [Abstract][Full Text] [Related]
23. Micelle-enhanced spectrofluorimetric method for determination of cholesterol-reducing drug ezetimibe in dosage forms.
Alarfaj NA; Aly FA
J Fluoresc; 2012 Jan; 22(1):9-15. PubMed ID: 21858740
[TBL] [Abstract][Full Text] [Related]
24. Validated spectrofluorimetric method for the determination of clonazepam in pharmaceutical preparations.
Ibrahim F; El-Enany N; Shalan S; Elsharawy R
Luminescence; 2016 May; 31(3):682-7. PubMed ID: 26335592
[TBL] [Abstract][Full Text] [Related]
25. An eco-friendly stability-indicating spectrofluorimetric method for the determination of two anticancer stereoisomer drugs in their pharmaceutical preparations following micellar enhancement: Application to kinetic degradation studies.
El-Kimary EI; El-Yazbi AF
Spectrochim Acta A Mol Biomol Spectrosc; 2016 Jun; 163():145-53. PubMed ID: 27045788
[TBL] [Abstract][Full Text] [Related]
26. Spectrofluorimetric and stability-indicating thin layer chromatographic methods for determination of cabergoline, a prolactin inhibitor in pharmaceuticals.
Rizk M; Mahmoud ZM; Azab MM
Spectrochim Acta A Mol Biomol Spectrosc; 2022 Nov; 281():121639. PubMed ID: 35872427
[TBL] [Abstract][Full Text] [Related]
27. Development and Validation of highly Sensitive Stability Indicating Spectrofluorimetric Method for Determination of Amlodipine in Pharmaceutical Preparations and Human Plasma.
Mohamed AI; Omar MA; Hammad MA; Mohamed AA
J Fluoresc; 2016 Nov; 26(6):2141-2149. PubMed ID: 27566613
[TBL] [Abstract][Full Text] [Related]
28. Validated stability-indicating liquid chromatographic method for the determination of ribavirin in the presence of its degradation products: application to degradation kinetics.
Belal F; Sharaf El-Din MK; Eid MI; El-Gamal RM
J Chromatogr Sci; 2015 Apr; 53(4):603-11. PubMed ID: 25092904
[TBL] [Abstract][Full Text] [Related]
29. Spectrofluorimetric determination of oxamniquine in dosage forms and spiked human plasma through derivatization with 1-dimethylaminonaphthalene-5-sulphonyl chloride.
El-Enany N; Belal F; Rizk M
J Fluoresc; 2008 Mar; 18(2):349-55. PubMed ID: 18058206
[TBL] [Abstract][Full Text] [Related]
30. Validated spectrofluorimetric and spectrophotometric methods for the determination of brimonidine tartrate in ophthalmic solutions via derivatization with NBD-Cl. Application to stability study.
Ibrahim F; El-Enany N; El-Shaheny RN; Mikhail IE
Luminescence; 2015 May; 30(3):309-17. PubMed ID: 25044105
[TBL] [Abstract][Full Text] [Related]
31. Stability-indicating spectrofluorimetric method with enhanced sensitivity for determination of vancomycin hydrochloride in pharmaceuticals and spiked human plasma: Application to degradation kinetics.
El-Din MKS; Ibrahim F; El-Deen AK; Shimizu K
J Food Drug Anal; 2018 Apr; 26(2):834-841. PubMed ID: 29567255
[TBL] [Abstract][Full Text] [Related]
32. Spectrofluorimetric determination of dopamine receptor antagonist LE 300 in mice plasma.
Hefnawy M; Mohamed M; Abunassif M; Alanazi A; Al-Majed A; Jochen L; Mostafa GA
Luminescence; 2016 Feb; 31(1):63-6. PubMed ID: 25892547
[TBL] [Abstract][Full Text] [Related]
33. Spectrofluorimetric determination of acotiamide hydrochloride trihydrate in the presence of its oxidative degradation product.
Attia KAM; Nassar MWI; El-Olemy A; Ramzy S
Luminescence; 2018 Jun; 33(4):806-811. PubMed ID: 29637695
[TBL] [Abstract][Full Text] [Related]
34. Spectrofluorimetric determination of aliskiren in dosage forms and urine.
Aydoğmuş Z
Luminescence; 2012; 27(6):489-94. PubMed ID: 22290775
[TBL] [Abstract][Full Text] [Related]
35. Utility of ninhydrin reagent for spectrofluorimetric determination of heptaminol in human plasma.
Omar MA; Nagy DM; Halim ME
Luminescence; 2018 Sep; 33(6):1107-1112. PubMed ID: 29968975
[TBL] [Abstract][Full Text] [Related]
36. Spectrofluorimetric Determination of Famotidine in Pharmaceutical Preparations and Biological Fluids through Ternary Complex Formation with Some Lanthanide Ions: Application to Stability Studies.
Walash MI; El-Brashy A; El-Enany N; Wahba ME
Int J Biomed Sci; 2009 Jun; 5(2):158-68. PubMed ID: 23675130
[TBL] [Abstract][Full Text] [Related]
37. Spectrofluorimetric determination of paroxetine HCl in pharmaceuticals via derivatization with 4-chloro-7- nitrobenzo-2-oxa-1,3-diazole (NBD-Cl).
Walsh M; Belal F; El-Enany N; Elmansi H
J Fluoresc; 2011 Jan; 21(1):105-12. PubMed ID: 20593227
[TBL] [Abstract][Full Text] [Related]
38. Spectrophotometric and spectrofluorimetric determination of atomoxetine in pharmaceutical preparations.
Ulu ST
Pharmazie; 2011 Nov; 66(11):831-5. PubMed ID: 22204127
[TBL] [Abstract][Full Text] [Related]
39. Spectrofluorimetric determination of terbinafine hydrochloride and linezolid in their dosage forms and human plasma.
Belal F; El-Din MK; Eid MI; El-Gamal RM
J Fluoresc; 2013 Sep; 23(5):1077-87. PubMed ID: 23722995
[TBL] [Abstract][Full Text] [Related]
40. Determination of the lipophilic antipsychotic drug ziprasidone in rat plasma and brain tissue using liquid chromatography-tandem mass spectrometry.
Zhang G; Terry AV; Bartlett MG
Biomed Chromatogr; 2008 Jul; 22(7):770-8. PubMed ID: 18318016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
